The external reference pricing reevaluation system is expected to be soon launched by the Korean government. At the 9th meeting held on the 10th of this month, there were disagreements over the specific details, but no change had been made in the big picture. The health authorities are reportedly planning to finalize the discussions within this month.

According to industry sources on the 14th, the health authorities are expected to hold another meeting with the pharmaceutical industry within the month and conclude the opinion-gathering process. At this pace, the reevaluations may begin as early as the second half of the year.

An industry insider said, "I can't share specific details du